Log in to save to my catalogue

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis an...

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_876bc134c9284335b9606279982c1274

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy

About this item

Full title

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy

Publisher

London: BioMed Central Ltd

Journal title

Genome medicine, 2022-09, Vol.14 (1), p.1-105, Article 105

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Renal cell carcinoma (RCC) is a heterogeneous disease comprising histologically defined subtypes. For therapy selection, precise subtype identification and individualized prognosis are mandatory, but currently limited. Our aim was to refine subtyping and outcome prediction across main subtypes, assuming that a tumor is composed of molecu...

Alternative Titles

Full title

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_876bc134c9284335b9606279982c1274

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_876bc134c9284335b9606279982c1274

Other Identifiers

ISSN

1756-994X

E-ISSN

1756-994X

DOI

10.1186/s13073-022-01105-y

How to access this item